An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer - Tulchinsky, H; Shmueli, E; Figer, A; Klausner, J M; Rabau, M (Ann Surg Oncol, 2008)